VELOCITY is a precision marketing solution, offering unmatched national peer-to-peer impact for healthcare companies. Deliver a multi-market message by key opinion leaders (KOLs) and accelerate market share.
VELOCITY transforms a traditional podium talk or demonstration into a stunning national event, transporting KOLs to a place where possibility becomes practice. Without the proposition of time away from the office. And without the rigors and expense of travel.
VELOCITY events are engineered to captivate, educate and influence KOLs where they reside. Showcase your company's latest breakthrough with a dynamic broadcast event live from one of America's most advanced High-Definition television studios.
And with the interactive Mind Over Matter Business Intelligence Suite, the audience is able to offer immediate insight as well as ask live questions. Imagine having the power to reach 10,000 physicians across 200 locations in the world's top markets during a single session.
VELOCITY experiential events for healthcare audiences
have featured numerous KOLs, including:
Dr. Bob Arnot, also known as Dr. Danger, is a physician, longtime NBC News correspondent and international humanitarian with a desire to introduce audiences to important issues and exotic locations around the world.
Dr. Anthony V. Benedetto, clinical associate professor of dermatology at the University of Pennsylvania School of Medicine. He is the author of 65 articles in peer review journals and editor of two editions of a textbook on botulinum toxins.
Dr. Jennifer Bolen, founder of The Legal Side of Pain and one of the foremost legal authorities on pain management in the nation.
Michael J. Coyle, executive vice president and group president of Cardiac and Vascular Group for Medtronic.
Dr. Larry Epstein, chief of Cardiac Arrhythmia Service at Brigham and Women's Hospital.
Dr. Ziv Haskal, author and principal investigator for the University of Maryland Medical Center. He has delivered more than 400 invited national and international lectures and has served as a visiting professor at institutions around the world.
Dr. Clifford Hudis, chief of Breast Cancer Medicine Service for Memorial Sloan-Kettering Cancer Center.
Steve Hurson, chief scientist at Nobel Biocare USA.
Dr. Barry T. Katzen, founder and medical director of Baptist Cardiac and Vascular Institute.
Dr. David Kendall, executive director of Medical Affairs for Amylin Pharmaceuticals, Inc.
Dr. Martin Leon, professor of medicine and associate director of Columbia University Medical Center. A renowned interventional cardiologist, Dr. Leon is founder and chairman of the Cardiovascular Research Foundation.
Pat Mackin, senior vice president and president of Cardiac Rhythm Disease Management for Medtronic.
Dr. Alan Moses, global chief medical officer for Novo Nordisk. He works closely with Denmark on global Novo Nordisk research and development programs in diabetes.
Dr. Ronald B. Natale, medical director of the Clinical Lung Cancer Program at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Cancer Center. He is a nationally renowned oncologist.
Dr. Peter Salgo, associate director of the Open Heart ICU at New York Presbyterian Hospital in New York City and an Emmy Award-winning medical journalist, practicing physician, and respected health-care futurist.
Dr. Hartzell V. Schaff, professor of surgery and chair of the Division of Cardiovascular Surgery at the Mayo Clinic.
Dr. Charles Simonton, chief medical officer and divisional vice president of Medical Sciences for Abbott Vascular.
Dr. Dennis Slamon, chief of hematology/oncology at the David Geffen School of Medicine at UCLA and developer of the breast cancer drug Herceptin, which spawned the Lifetime movie Living Proof about his research.
Dr. Ron Waksman, associate director of the Division of Cardiology for Washington Hospital Center.